Trial · NCT01387607
Results by group74
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 74
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Endpoint Mean Pain Score During the Double-blind Treatment Period at Week 14 | Pregabalin | -2.01 | Standard Error 0.148 | Units on a scale | |
| Change From Baseline in Endpoint Mean Pain Score During the Double-blind Treatment Period at Week 14 | Placebo | -1.28 | Standard Error 0.150 | Units on a scale | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | Very much improved | 9.9 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | Very much improved | 7.7 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | Much improved | 25.4 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | Much improved | 19.7 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | Minimally improved | 40.1 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | Minimally improved | 42.3 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | No change | 17.6 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | No change | 24.6 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | Minimally worse | 4.9 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | Minimally worse | 3.5 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | Much worse | 2.1 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | Much worse | 2.1 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Pregabalin | Very much worse | 0.0 | Percentage of participants | |
| Percentage of Participants Categorized by Each Patient Global Impression of Change (PGIC) Score at Week 14 | Placebo | Very much worse | 0.0 | Percentage of participants | |
| Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) Total Score at Week 14 | Pregabalin | -11.14 | Standard Error 1.343 | Units on a scale | |
| Change From Baseline in Fibromyalgia Impact Questionnaire (FIQ) Total Score at Week 14 | Placebo | -8.15 | Standard Error 1.367 | Units on a scale | |
| Percentage of Participants With at Least 30% Reduction in Weekly Mean Pain Score From Baseline to Week 14 | Pregabalin | 47.5 | Percentage of participants | ||
| Percentage of Participants With at Least 30% Reduction in Weekly Mean Pain Score From Baseline to Week 14 | Placebo | 32.7 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01387607/results